526445 — Indrayani Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.81bn
- IN₹3.72bn
- IN₹1.66bn
- 10
- 33
- 31
- 10
Annual cashflow statement for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -109 | 42.3 | 119 | 104 |
| Depreciation | ||||
| Non-Cash Items | 21.2 | — | 10.6 | 98.8 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 88.8 | -11 | -1.48 | -545 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 5.18 | 34.7 | 162 | -304 |
| Capital Expenditures | -3.83 | -0.631 | -239 | -165 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -1.8 | 6.49 | -235 | 1.48 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -5.63 | 5.86 | -474 | -163 |
| Financing Cash Flow Items | -19.4 | -18.6 | -127 | 32.3 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -7.3 | -32.3 | 327 | 442 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -7.76 | 8.19 | 15.3 | -24.5 |